Sort
39,280 grants matching “leukemia”
Mechanisms of Neural Crest Cell Development
$354,196Ching-Pin Chang · Stanford University · R01 · FY2009 · HL
Understanding Ikaros molecular functions for targeted therapies of pre-B ALL
$354,184Hilde Schjerven · University Of California, San Francisco · R01 · FY2022 · CA
The pathogenesis of chromosome 7q deletions in juvenile myelomonocytic leukemia
$354,174Megan McNerney · University Of Chicago · R01 · FY2019 · CA
Targeting Regulators of Apoptosis in AML
$354,155Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA
In vivo targeting of hematopoetic cells with glycan ligands of siglecs
$354,146James C. Paulson · Scripps Research Institute, The · R01 · FY2013 · CA
MODULATION OF IFN ACTION VIA NOVEL REGULATORY FACTORS
$354,086University Of Maryland Baltimore · R01 · FY2001 · CA
Defining the determinants of response and resistance to therapy for Richter's Syndrome
$354,075Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2024 · CA
The Core Apoptotic Pathway Controlling Glucocorticoid-induced Apoptosis in ALL
$354,060Scott A Armstrong · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
$354,054Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2010 · CA
NextGen - CHOP
$354,050John M Maris · Children'S Hosp Of Philadelphia · OT2 · FY2024 · CA
Development and Application of Biomarkers of Exposure - Biomedical
$354,049Stephen M Rappaport · Univ Of North Carolina Chapel Hill · P42 · FY2009 · ES
Mechanism of Normal and Ocogenic Kit Signaling in Vivo
$354,038Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · HL
(PQ2) Donor socioeconomic status as a predictor of altered immune function and treatment response following hematopoietic cell transplantation for hematologic malignancy
$354,037Jennifer Mary Knight · Medical College Of Wisconsin · R01 · FY2021 · CA
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation
$354,028Samuel Strober · Stanford University · P01 · FY2012 · HL
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation
$354,028Samuel Strober · Stanford University · P01 · FY2010 · HL
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation
$354,028Samuel Strober · Stanford University · P01 · FY2011 · HL
Project 1: Molecular Pathogenesis and Therapy of Myelofibrosis
$354,021Ross L Levine · Icahn School Of Medicine At Mount Sinai · P01 · FY2022 · CA
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors
$354,018David W Russell · University Of Washington · R01 · FY2007 · HL
THYMOMA TYROSINE PROTEIN KINASE
$354,008Salk Institute For Biological Studies · R01 · FY2000 · CA
Elucidation of the mechanisms by which fatty acids drive megakaryopoiesis
$354,000Kellie Rae Machlus · Boston Children'S Hospital · R01 · FY2024 · DK
Elucidation of the mechanisms by which fatty acids drive megakaryopoiesis
$354,000Kellie Rae Machlus · Boston Children'S Hospital · R01 · FY2025 · DK
FLT3 as a Target for Drug Discovery to Treat Leukemia
$353,997Johns Hopkins University · U01 · FY2004 · CA
Terminal Transferase and Lymphocyte Development
$353,981John Franklin Kearney · University Of Alabama At Birmingham · R01 · FY2006 · AI
How Insulin/IGF-1 Deficiencies Retard Mammalian Aging
$353,967David E Harrison · Jackson Laboratory · R01 · FY2007 · AG
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
$353,933Jing Zhang · University Of Wisconsin-Madison · R01 · FY2019 · CA